Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment. | JCI Insight | 2023 | 36795489 | PubTator, text mining | PubMed |
| METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. | EMBO Rep | 2023 | 36794620 | PubTator, text mining | PubMed |
| Association between autophagy and acute pancreatitis. | Front Genet | 2023 | 36793898 | PubTator, text mining | PubMed |
| METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3. | Regen Ther | 2023 | 36793308 | PubTator, text mining | PubMed |
| Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation. | Aging (Albany NY) | 2023 | 36791151 | PubTator, text mining | PubMed |
| N6-Methyladenosine RNA Modification in Host Cells Regulates Peste des Petits Ruminants Virus Replication. | Microbiol Spectr | 2023 | 36786625 | PubTator, text mining | PubMed |
| Diagnostic, clustering, and immune cell infiltration analysis of m6A regulators in patients with sepsis. | Sci Rep | 2023 | 36781867 | PubTator, text mining | PubMed |
| m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner. | Cell Death Dis | 2023 | 36781839 | PubTator, text mining | PubMed |
| N6-methyladenine regulator-mediated RNA methylation modification patterns in immune microenvironment regulation of osteoarthritis. | Front Genet | 2023 | 36777725 | PubTator, text mining | PubMed |
| Identifying RNA Modifications by Direct RNA Sequencing Reveals Complexity of Epitranscriptomic Dynamics in Rice. | Genomics Proteomics Bioinformatics | 2023 | 36775055 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC. | Sci Rep | 2023 | 36774418 | PubTator, text mining | PubMed |
| Systematic identification of factors involved in the silencing of germline genes in mouse embryonic stem cells. | Nucleic Acids Res | 2023 | 36772830 | PubTator, text mining | PubMed |
| Current Insights into m6A RNA Methylation and Its Emerging Role in Plant Circadian Clock. | Plants (Basel) | 2023 | 36771711 | PubTator, text mining | PubMed |
| Longevity, Centenarians and Modified Cellular Proteodynamics. | Int J Mol Sci | 2023 | 36769212 | PubTator, text mining | PubMed |
| The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses. | Int J Mol Sci | 2023 | 36768716 | PubTator, text mining | PubMed |
| Regulation of Gene Expression by m6Am RNA Modification. | Int J Mol Sci | 2023 | 36768600 | PubTator, text mining | PubMed |
F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner. | Cancers (Basel) | 2023 | 36765911 | PubTator, text mining | PubMed |
| Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. | Hum Genomics | 2023 | 36765416 | PubTator, text mining | PubMed |
| METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer. | Breast Cancer Res | 2023 | 36765397 | PubTator, text mining | PubMed |
| O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. | Signal Transduct Target Ther | 2023 | 36765030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=69